FMED vs IBB5YFMEDFMEDAvsBIBBIBBFidelity Disruptive Medicine ETF · $53MiShares Biotechnology ETF · $10.8BReturns · dividends in+17.7%3 years · per year$16,305 · $18,044+21.7%[…]5 years · per year[…] · $13,476+6.1%Cost and income0.50%Expense ratio$50 · $44 on $10k · lower wins0.44%0.00%12-mo yield$0 · $16 on $10k0.16%
Overlap: FMED, IBB, VGTToday0.0%most shared, IBB and VGTFMEDIBBVGTFMED—[…][…]IBB[…]—0.0%VGT[…]0.0%—End-of-day Nov 17, 2026 · share held in common · outlined: the pair in versus
FMED vs IBB5YAFMEDFidelity Disruptive Medicine[…]vsIBBBiShares Biotechnology$13,476MeasureFMEDIBBFee0.50%0.44%Cost on $10k a year$50$44Yield0.00%0.16%5 years, per year[…]+6.1%3 years, per year+17.7%+21.7%Worst drop · 1Y−18.3%−9.6%Volatility · 1Y24.4%
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1VGTVanguard Information Technology ETFReadDesk0.09%0.44%−0.9%+13.8%+13.5%+24.9%+14.4%−17.7%$145.1B2BIBBiShares Biotechnology ETFReadDesk0.44%0.16%−0.5%+22.7%+26.3%+21.7%+6.1%−9.6%$10.8B3AFMEDFidelity Disruptive Medicine ETFReadDesk0.50%0.00%0.0%+21.0%+21.4%+17.7%new−18.3%$53MEnd-of-day Nov 17, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1VGTVanguard Information Technology ETFReadDesk0.09%0.44%−0.9%+13.8%+13.5%+24.9%+14.4%−17.7%$145.1B2BIBBiShares Biotechnology ETFReadDesk0.44%0.16%−0.5%+22.7%+26.3%+21.7%+6.1%−9.6%$10.8B3AFMEDFidelity Disruptive Medicine ETFReadDesk0.50%0.00%0.0%+21.0%+21.4%+17.7%new−18.3%$53MEnd-of-day Nov 17, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
XLK vs VGTYTDSPDRXLKSA+13.8%vsBVVGTVanguard+13.8%Jan 1Nov 17+13.8%+13.8%+13.8%Year to date+13.8%0.08% · $8Fee · on $10k a year0.09% · $9$117BAssets$145B1–0XLK winsEnd-of-day Nov 17, 2026
SCHD vs VIGYTDSchwabSCHDSA+31.9%vsBVVIGVanguard+13.4%Jan 1Nov 17+31.9%+13.4%+31.9%Year to date+13.4%3.0%Yield1.5%$124BAssets$116B2–0SCHD winsEnd-of-day Nov 17, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA+3.4%vsBJMJEPIJ.P. Morgan+5.7%Jan 1Nov 17+3.4%+5.7%+3.4%Year to date+5.7%12.8%Yield8.1%$42.1BAssets$47.0B1–1levelEnd-of-day Nov 17, 2026
Overlap: FMED, IBB, VGTToday0.0%most shared, IBB and VGTFMEDIBBVGTFMED—[…][…]IBB[…]—0.0%VGT[…]0.0%—End-of-day Nov 17, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$35most kept, VGTVGT$44 − $9 = $35IBB$16 − $44 = −$28FMED$0 − $50 = −$50KeptFeeEnd-of-day Nov 17, 2026 · yield in dollars minus the fee